A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Popularity Online
The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Concerns
However, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could result in individuals administering products of unknown origin.
Some professionals said the demand for the experimental drug could be connected to the rising price of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.
Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Service Reaction and Content Elimination
According to the social media company, the platform has taken down problematic material and banned associated hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Investigations also discovered communities with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, populated with photos of slimming results, positive testimonials and detailed instructions for preparing or injecting at home.
Within moments of joining one group, a vendor posted WhatsApp details, where most purchases take place. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.
Product Information and Pricing
Inside these communities, posts show dark colored packages with postal service labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service said it regularly moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they cannot confirm. Even if the science behind retatrutide is sound, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.
Her team has previously encountered individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose patients to potentially significant health risks”.
